Publications by authors named "Jerome LePavec"
Rational: Pending the authorization of new anti-CMV drugs with fewer adverse effects, exploring the possibilities offered by CMV immunoglobulins (CMVIG) seems necessary. In France, access to CMVIG requires official authorization by the national Health authority and is restricted to second line rescue therapy for CMV infection/disease. The aim of this multicenter retrospective study is to describe the indications and clinical situations that justified its use in France.
View Article and Find Full Text PDFArticle Synopsis
- Lung cancer is often treated with surgery, but many patients also deal with pulmonary hypertension (PH), which complicates their care and may even lead to surgery being denied.
- A literature review focused on the challenges and guidelines associated with lung resection in patients with PH highlights the importance of thorough preoperative assessments.
- Expert recommendations emphasize the need for specialized evaluation and management to improve outcomes for lung cancer patients with pulmonary hypertension.